IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 52.18

Change

-0.10 (-0.19)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-19 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+0.08 (+0.05%)

USD 37.98B
FHLC Fidelity® MSCI Health Care In..

+0.14 (+0.20%)

USD 2.70B
FXH First Trust Health Care AlphaD..

+0.26 (+0.25%)

USD 1.01B
XHE SPDR® S&P Health Care Equipme..

+0.87 (+1.05%)

USD 0.18B
IDNA iShares Genomics Immunology an..

+0.08 (+0.38%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF

+0.45 (+1.47%)

USD 0.09B
XHS SPDR® S&P Health Care Service..

+0.61 (+0.63%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

+0.18 (+0.64%)

USD 0.05B
BBP Virtus LifeSci Biotech Product..

+1.05 (+1.74%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.39 (+1.97%)

USD 6.67M

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 10.16 % 0.00 %

+0.29 (+1.06%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.73% 100% F 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.73% 100% F 85% B
Trailing 12 Months  
Capital Gain -3.66% 24% F 31% F
Dividend Return 0.76% 63% D 13% F
Total Return -2.90% 24% F 26% F
Trailing 5 Years  
Capital Gain 84.38% 90% A- 56% F
Dividend Return 7.36% 63% D 12% F
Total Return 91.75% 76% C+ 48% F
Average Annual (5 Year Horizon)  
Capital Gain 4.73% 62% D 50% F
Dividend Return 5.37% 62% D 44% F
Total Return 0.65% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 21.52% 43% F 50% F
Risk Adjusted Return 24.97% 57% F 39% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.